The Next Generation Migraine Therapies (NGMT) initiative is a comprehensive program designed to provide a multi-faceted approach to migraine education offered at no cost to healthcare providers. Brought to you by the American Headache Society, the program covers diagnosis and treatment of migraine and updates on the latest science.Book Now
WHO SHOULD ATTEND
This program is designed for neurologists, family practitioners, internists and other health professionals who would like more information on the proper diagnosis and treatment of chronic migraine patients.
At the conclusion of this activity, attendees should be better able to:
- Recognize the prevalence and epidemiology of migraine and unmet needs on current treatments
- Discuss insights from basic science that underlie the next generation of migraine therapeutics
- Utilize calcitonin gene-related peptide (CGRP)-targeted therapies in migraine prevention
- Individualize and optimize migraine treatment using current and emerging therapeutic options
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The American Headache Society® designates this Live Activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For those who register and participate in the Education On Demand program:
The American Headache Society® designates this Enduring Material for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For those who register and attend a live Q&A session after viewing the enduring material:
The American Headache Society® designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
INSTRUCTIONS FOR CLAIMING CME
- Attend sessions for which credit is sought in full (this includes watching on-demand courses).
- Complete the post-activity evaluation.
- A certificate of completion will be available once the evaluation is submitted.
The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
DISCLOSURE OF COMMERICAL SUPPORT
Lilly USA, LLC
|Next Generation Migraine Therapies
December 3, 2022 | Atlanta, GA
Embassy Suites by Hilton Atlanta Buckhead | Phoenix Ballroom
|7:00 am – 7:45 am||Course Registration and Continental Breakfast|
|7:45 am – 8:00 am||Introduction, Program Overview and Pre-test|
|8:00 am – 9:00 am||Overview of Migraine|
|8:00 am – 8:20 am||Migraine: Making the Diagnosis|
|8:20 am – 8:45 am||How Do I Explain Migraine to My Patients?|
|8:45 am – 9:00 am||Q&A|
|9:00 am – 10:15 am||Next Generation Acute Treatment: Addressing Unmet Needs|
|9:00 am – 9:30 am||Overview of Acute Treatment and Best Practices in Migraine|
|9:30 am – 10:00 am||Advances in Acute Therapies for Migraine and How to Integrate Them Into Your Practice: New Formulations, Ditans and Gepants|
|10:00 am – 10:15 am||Q&A|
|10:15 am – 10:30 am||Break|
|10:30 am – 12:00 pm||Next Generation Preventive Treatment|
|10:30 am – 10:45 am||How Do We Approach Preventive Migraine Treatment?|
|10:45 am – 11:10 am||Monoclonal Antibodies Targeting CGRP and Gepants|
|11:10 am – 11:30 am||Behavioral Treatments for Migraine|
|11:30 am – 11:50 am||Updates in Pediatric Migraine|
|11:50 am – 12:00 pm||Q&A|
|12:00 pm – 1:15 pm||Working Lunch: Case Discussions|
|1:15 pm – 1:30 pm||Break|
|1:30 pm – 3:45 pm||Procedures, Devices and Non-pharmacological Treatment Workshops
Attendees will be broken into two (2) groups. Each group will be assigned a workshop initially and then switch to the other at the break allowing attendees to attend both workshops. Workshop assignment is noted on the back of the attendee name badge.
|1:30 pm – 2:30 pm||Workshop 1: Procedures|
|1:30 pm – 2:00 pm||OnabotulinumtoxinA: Nerve Blocks and Other Procedures for Migraine|
|2:00 pm – 2:30 pm||Headache Procedures: Hands-on Training|
|1:30 pm – 2:30 pm||Workshop 2: Nonpharmacologic Treatments|
|1:30 pm – 2:00 pm||Behavioral Enhancements to Migraine Management|
|2:00 pm – 2:30 pm||Neuromodulation for Migraine: Current and Future Devices|
|2:30 pm – 2:45 pm||Break (attendees switch rooms-workshops repeat)|
|2:45 pm – 3:45 pm||Workshop 1: Procedures|
|2:45 pm – 3:15 pm||OnabotulinumtoxinA: Nerve Blocks and Other Procedures for Migraine|
|3:15 pm – 3:45 pm||Headache Procedures: Hands-on Training|
|2:45 pm – 3:45 pm||Workshop 2: Nonpharmacologic Treatments|
|2:45 pm – 3:15 pm||Behavioral Enhancements to Migraine Management|
|3:15 pm – 3:45 pm||Neuromodulation for Migraine: Current and Future Devices|
|3:45 pm||Closing Remarks and Evaluations|
Online registration is now open. To register at no cost, click here.Book Now
Embassy Suites by Hilton Atlanta Buckhead
3285 Peachtree Road NE
Atlanta, GA 30305
AHS has booked a block of hotel rooms for attendees who want to spend the night. The group rate is $145/night (+tax). The group rate expires on November 9 or when the block sells out (whichever comes first). Please book early to secure your room at the group rate. Book using this link.
If you drive to the workshop, we have a discounted parking rate at the conference hotel of $20/day.
Unable to attend Next Generation Migraine Therapies in-person? Register for the Education On Demand program to view past NGMT content for up to 2.75 AMA PRA Category 1 Credits™
|Pre-recorded Lectures Available On Demand|
|Introduction and Program Overview
Kathleen B. Digre, MD, FAHS
|Migraine Diagnosis, Epidemiology, and Pathophysiology
Kathleen B. Digre, MD, FAHS
|What’s New in Acute Migraine Treatment
Stewart J. Tepper, MD, FAHS
|Behavioral Approaches in Migraine Management
Dawn C. Buse, PhD, FAHS
|What’s New in Migraine Prevention
Michael Marmura, MD, FAHS
AHS gratefully acknowledges sponsorship of the 2022 Next Generation Migraine Therapies Program from our industry supporters:
AHS gratefully acknowledges educational grant support of the 2022 Next Generation Migraine Therapies Program from our industry supporters:
|Lilly USA, LLC|